NO20090164L - Kombinasjonsfremstillinger innbefattende SLV308 og en L-DOPA - Google Patents
Kombinasjonsfremstillinger innbefattende SLV308 og en L-DOPAInfo
- Publication number
- NO20090164L NO20090164L NO20090164A NO20090164A NO20090164L NO 20090164 L NO20090164 L NO 20090164L NO 20090164 A NO20090164 A NO 20090164A NO 20090164 A NO20090164 A NO 20090164A NO 20090164 L NO20090164 L NO 20090164L
- Authority
- NO
- Norway
- Prior art keywords
- slv308
- dopa
- preparations including
- combination preparations
- simultaneous
- Prior art date
Links
- YVPUUUDAZYFFQT-UHFFFAOYSA-N 7-(4-methylpiperazin-1-yl)-3h-1,3-benzoxazol-2-one Chemical compound C1CN(C)CCN1C1=CC=CC2=C1OC(=O)N2 YVPUUUDAZYFFQT-UHFFFAOYSA-N 0.000 title abstract 2
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 title abstract 2
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 title abstract 2
- 238000002360 preparation method Methods 0.000 title abstract 2
- 150000001204 N-oxides Chemical class 0.000 abstract 1
- 208000018737 Parkinson disease Diseases 0.000 abstract 1
- 208000005793 Restless legs syndrome Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 230000010249 dopaminergic function Effects 0.000 abstract 1
- 238000011084 recovery Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Oppfinnelsen angår anvendelsen av et kombinasjonspreparat av SLV308 eller dets N-oksid, eller farmakologisk akseptable salter av disse forbindelsene (I), (II) og L-DOPA, for samtidig, separat eller sekvensiell anvendelse i behandlingen av lidelser som krever gjenvinning av dopaminergisk funksjon, spesielt Parkinsons sykdom og rastløse ben syndrom.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US81405106P | 2006-06-16 | 2006-06-16 | |
EP06115583 | 2006-06-16 | ||
PCT/EP2007/055955 WO2007144421A1 (en) | 2006-06-16 | 2007-06-15 | Combination preparations comprising slv308 and a l-dopa |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20090164L true NO20090164L (no) | 2009-01-14 |
Family
ID=38434785
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20090164A NO20090164L (no) | 2006-06-16 | 2009-01-12 | Kombinasjonsfremstillinger innbefattende SLV308 og en L-DOPA |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP2035002A1 (no) |
JP (1) | JP2009539941A (no) |
KR (1) | KR20090031908A (no) |
AU (1) | AU2007259255A1 (no) |
CA (1) | CA2654719A1 (no) |
EA (1) | EA015073B1 (no) |
IL (1) | IL195532A0 (no) |
MY (1) | MY148457A (no) |
NO (1) | NO20090164L (no) |
WO (1) | WO2007144421A1 (no) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0027020D0 (en) | 2000-11-03 | 2000-12-20 | Univ Manchester | Treatment of movement disorders |
US20090247537A1 (en) * | 2008-03-25 | 2009-10-01 | William Dale Overfield | Methods for preventing or treating bruxism using dopaminergic agents |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7596407B2 (en) * | 2004-03-26 | 2009-09-29 | Solvay Pharmaceuticals, B.V. | Transdermal iontophoretic delivery of piperazinyl-2(3H)-benzoxazolone compounds |
WO2006032202A1 (en) * | 2004-09-21 | 2006-03-30 | Shandong Luye Pharmaceutical Co., Ltd. | Long acting sustained-release formulation containing dopamine receptor agonist and the preparation method thereof |
EP1919883B1 (en) * | 2005-08-22 | 2008-12-17 | Solvay Pharmaceuticals B.V. | N-oxides as prodrugs of piperazine&piperidine derivatives |
-
2007
- 2007-06-15 WO PCT/EP2007/055955 patent/WO2007144421A1/en active Search and Examination
- 2007-06-15 CA CA002654719A patent/CA2654719A1/en not_active Abandoned
- 2007-06-15 MY MYPI20085078A patent/MY148457A/en unknown
- 2007-06-15 KR KR1020097001024A patent/KR20090031908A/ko not_active Application Discontinuation
- 2007-06-15 JP JP2009514809A patent/JP2009539941A/ja active Pending
- 2007-06-15 EA EA200970021A patent/EA015073B1/ru not_active IP Right Cessation
- 2007-06-15 AU AU2007259255A patent/AU2007259255A1/en not_active Abandoned
- 2007-06-15 EP EP07730193A patent/EP2035002A1/en not_active Withdrawn
-
2008
- 2008-11-26 IL IL195532A patent/IL195532A0/en unknown
-
2009
- 2009-01-12 NO NO20090164A patent/NO20090164L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2007144421A1 (en) | 2007-12-21 |
IL195532A0 (en) | 2009-09-01 |
EA200970021A1 (ru) | 2009-06-30 |
CA2654719A1 (en) | 2007-12-21 |
KR20090031908A (ko) | 2009-03-30 |
MY148457A (en) | 2013-04-30 |
AU2007259255A1 (en) | 2007-12-21 |
EA015073B1 (ru) | 2011-04-29 |
JP2009539941A (ja) | 2009-11-19 |
EP2035002A1 (en) | 2009-03-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK2023918T3 (da) | Cyclosporiner til behandlingen og forebyggelse af okulære lidelser | |
MX2009011359A (es) | Derivados de pirimidinona y sus metodos de uso. | |
NO20081592L (no) | Dipeptidylpeptidaseinhibitorer for behandling av diabetes | |
JO2756B1 (en) | The second preparation of aqueous pyrimidnon containing 4- (4-ciano-2-2 thiourail) and its use) | |
GEP20125701B (en) | Application of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2h-pyrimidin-1-ylmethyl]-4-fluoro-benzonitrile | |
NO20082768L (no) | Levodopa prodroge mesylat, sammensetninger og anvendelser derav | |
NO20084752L (no) | Konjugater av aziridinayl-epotilonanaloger og farmasoytiske sammensetninger som inneholder disse | |
TNSN06053A1 (en) | 6-substituted anilino purines as rtk inhibitors | |
WO2009071690A3 (de) | 5,6-disubstituierte oxindol-derivate und ihre verwendung zur behandlung von vasopressin-abhängigen erkrankungen | |
MX2009009416A (es) | Derivados de bencimidazol y sus metodos de uso. | |
MX2020008616A (es) | Rocio de fentanilo sublingual. | |
TW200633992A (en) | Biaryloxymethylarenecarboxylic acids | |
NO20090165L (no) | Kombinasjonsfremstillinger innbefattende bifeprunox og L-DOPA | |
NO20085257L (no) | Purinonderivater som HM74a-agonister | |
NO20085099L (no) | Puritonderivativer som HM74A agonister | |
WO2009071689A3 (de) | 5-halogen-substituierte oxindol-derivate und ihre verwendung zur behandlung von vasopressin-abhängigen erkrankungen | |
DK2013166T3 (da) | N-carbamoylmethyl-4(R)-phenyl-2-pyrrolidon, fremgangsmåde til fremstilling heraf og farmaceutisk anvendelse | |
UA102238C2 (en) | 4-(4-cyano-2-thioaryl)dihydro-pyrimidinones and use thereof | |
UA92730C2 (ru) | Аналоги бензазола и их применение | |
WO2008008882A3 (en) | Glucocorticoid receptor modulator and methods of use | |
DK2175877T3 (da) | Anvendelse af muterede antitrombiner til behandling eller forebyggelse af koagulationssygdomme | |
NO20090164L (no) | Kombinasjonsfremstillinger innbefattende SLV308 og en L-DOPA | |
WO2007144699A3 (en) | Process for the preparation of alfuzosin | |
CY1116166T1 (el) | Νεα μεθοδος για την αντιμετωπιση λοιμωξεων απο η.pylori | |
MX2012001107A (es) | Derivado de amida. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |